Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 1998

View Archived Issues

Company Profile: Select Therapeutics

Genelabs Technologies: Q4 and year-end 1997 highlights

Anesta: year-end 1997 highlights

Texas Biotechnology: Q4 1997 highlights

Virus Research Institute: Q4 and FY 1997 highlights

Annual Report 1996/1997: Asta Medica

First approvals for Zadaxin outside Asia

Patent coverage for Metabasis Therapeutics' adenosine kinase inhibitors

Novel antiviral agents from Lilly

Bristol-Myers Squibb developing new paclitaxel derivatives

Corvas prepares new orally active antithrombotic agents

S-8921: specific inhibitor of ileal bile acid transport for hypercholesterolemia

Profile of a motilide: Abbott's ABT-229

Takeda in negotiations with potential marketing partner for pioglitazone

Kirin Brewery will collaborate with Chugai on PB-94 development

Antioxidant and neuroprotective effects of GSNO confirmed

Yamanouchi terminates IFN marketing agreement with Schering-Plough

Nicotine inhaler launched in U.S.

Gene delivery technology offered for licensing

ICAgen issued patents on novel ion channel drug discovery technology

Naked DNA delivery technology offered for licensing

LXR and Copernicus establish cancer gene therapy collaboration

Pharmacodynamics of HMR-3647 against respiratory pathogens, enterococci and B. fragilis

New company created for development of cell therapies

Lilly glycopeptide antibiotic compared to vancomycin and teicoplanin in vitro

New compound for mucositis in development at Alizyme

HBED proposed as alternative to deferoxamine as iron chelator

FDA requests additional information for EchoGen NDA review

NIH offers new technology for licensing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....